Apeloa Pharmaceutical Co Ltd (000739) — Capital Reinvestment Ratio
Latest as of December 2025:
0.37x
Apeloa Pharmaceutical Co Ltd (000739) has a Capital Reinvestment Ratio of 0.37x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥446.18 Million) in capital expenditures (CN¥166.73 Million). See 000739 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.37x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥446.18 Million
CNY
Capital Expenditures
CN¥166.73 Million
CNY
Data as of
Dec 2025
Most recent filing
Apeloa Pharmaceutical Co Ltd Capital Reinvestment Ratio (1998–2025)
This chart tracks Apeloa Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 26 annual periods.
Annual Capital Reinvestment Ratio for Apeloa Pharmaceutical Co Ltd (1998–2025)
Year-by-year Capital Reinvestment Ratio for Apeloa Pharmaceutical Co Ltd from 1998 to 2025. For live market cap and broader valuation context, see how much is Apeloa Pharmaceutical Co Ltd worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.31x | CN¥1.23 Billion | CN¥386.21 Million | ▼ -17.7% |
| 2024 | 0.38x | CN¥1.21 Billion | CN¥460.75 Million | ▼ -37.6% |
| 2023 | 0.61x | CN¥1.03 Billion | CN¥630.47 Million | ▲ +59.2% |
| 2022 | 0.38x | CN¥1.33 Billion | CN¥509.11 Million | ▼ -66.5% |
| 2021 | 1.15x | CN¥611.75 Million | CN¥701.92 Million | ▲ +283.4% |
| 2020 | 0.30x | CN¥1.06 Billion | CN¥317.12 Million | ▲ +1178.2% |
| 2019 | 0.02x | CN¥1.36 Billion | CN¥31.85 Million | ▼ -76.1% |
| 2018 | 0.10x | CN¥832.69 Million | CN¥81.62 Million | ▼ -87.4% |
| 2017 | 0.78x | CN¥209.80 Million | CN¥163.42 Million | ▼ -57.6% |
| 2016 | 1.84x | CN¥180.42 Million | CN¥331.35 Million | ▲ +79.2% |
| 2015 | 1.02x | CN¥441.16 Million | CN¥452.06 Million | ▲ +49.2% |
| 2014 | 0.69x | CN¥786.64 Million | CN¥540.22 Million | ▼ -74.1% |
| 2013 | 2.65x | CN¥190.45 Million | CN¥505.01 Million | ▲ +162.3% |
| 2012 | 1.01x | CN¥335.90 Million | CN¥339.59 Million | ▲ +41.4% |
| 2011 | 0.71x | CN¥404.62 Million | CN¥289.21 Million | ▼ -38.1% |
| 2010 | 1.15x | CN¥121.05 Million | CN¥139.81 Million | ▲ +156.9% |
| 2009 | 0.45x | CN¥208.30 Million | CN¥93.66 Million | ▼ -87.8% |
| 2008 | 3.69x | CN¥94.57 Million | CN¥349.04 Million | ▲ +455.7% |
| 2007 | 0.66x | CN¥174.20 Million | CN¥115.70 Million | ▲ +96.7% |
| 2006 | 0.34x | CN¥159.43 Million | CN¥53.84 Million | ▼ -75.7% |
| 2005 | 1.39x | CN¥87.40 Million | CN¥121.65 Million | ▼ -40.4% |
| 2004 | 2.34x | CN¥47.54 Million | CN¥111.07 Million | ▲ +179.4% |
| 2003 | 0.84x | CN¥105.36 Million | CN¥88.09 Million | ▼ -95.0% |
| 2002 | 16.78x | CN¥2.81 Million | CN¥47.23 Million | ▲ +3595.5% |
| 2000 | 0.45x | CN¥7.08 Million | CN¥3.22 Million | ▼ -16.8% |
| 1998 | 0.55x | CN¥30.10 Million | CN¥16.43 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow